The Miller School’s Bradley Goldstein, M.D., Ph.D., assistant professor of otolaryngology, has received a five-year, $1.1 million grant from the National Institutes of Health to study the role of stem cells in olfactory neuron regeneration. Goldstein focuses his clinical and research interests on olfactory disorders.
An international team of researchers, including Miller School pulmonologist Marilyn K. Glassberg, M.D., has confirmed the results of earlier trials that pirfenidone, a medication already approved for use in nearly three dozen countries, is effective in slowing the progress of idiopathic pulmonary fibrosis. Their findings were published in the May 20 issue of The New England Journal of Medicine.
A new Miller School research study has identified a safe and effective route for delivering stem cells to the brain, where they can potentially repair stroke-damaged tissue. "Our team found that delivering a low dose of mesenchymal stem cells (MSCs) through the carotid artery at 24 hours after stroke resulted in effective therapy for ischemic stroke in an animal model," said lead author Dileep Yavagal, M.D.